Features of Changes of Vascular Age and Cardiovascular Risk Level in Patients with Arterial Hypertension and Comorbid Chronic Obstructive Pulmonary Disease
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: Evaluate changes in vascular age and cardiovascular risk level with reference to the severity of chronic obstructive pulmonary disease (COPD) in patients with arterial hypertension (AH) and COPD.
Materials and methods. The study included 120 patients with hypertension stage II, grade 2, 3 and 3 in combination with COPD grade II–III and clinical groups A, B, C, D (group 1), 30 patients with AH without COPD (group 2), 30 patients with COPD without AH (group 3) and 30 healthy individuals (control group) representative by age and sex.
Results. In the group of patients with AH and comorbid COPD, more than 50% of patients corresponded to moderate CVR, more than a third to high CVR, and a very high risk was found in isolated cases. The analysis of the obtained data revealed a significant increase in vascular age relative to chronological in groups 1, 2 and 3, but in control group there was only a tendency to ahead of vascular age (p>0.05). The diagnostic value of indicators for determining the exacerbation of COPD in patients with hypertension and comorbid COPD was determined using ROC analysis, which showed the presence of prognostic value for the following factors: age (AUC 0.50; CI 0.41–0.59), pack-years (AUC 0.60; CI0.51–0.69), duration of COPD (AUC 0.60; CI 0.51–0.69).
Conclusion. The GP of the family medicine must evaluate the CVR on the SCORE scale as a screening technique. In the presence of comorbid COPD, the factor of disease duration becomes significant, which is an additional risk factor and affects the severity of CVR. Regardless of the comorbid pathology of AH and COPD, patients have a discrepancy between vascular and chronological age, which is a predictor of cardiovascular disease.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Hypertension in adults. Professional associations. Wedge. rivers Moscow: Russian Society of Cardiology; 202.
Order of the Ministry of Health of Ukraine dated 24.05.2012 № 384 «On approval and implementation of medical and technological documents for the standardization of medical care for hypertension».
Order of the Ministry of Health of Ukraine dated 27.06.2013 № 555 «On approval and implementation of medical and technological documents for the standardization of medical care for chronic obstructive pulmonary disease».
Nevzorova V.A, Zakharchuk N.V., Brodska TA, Sarafanova NS, Huliiev AA. Assessment of cardiovascular risk in chronic obstructive pulmonary disease using spirometry. Sib. Med. Review.
Svishchenko YeP, Mishchenko LA. A new concept for assessing cardiovascular risk according to Framingham criteria is to determine the age of blood vessels. The first experience of using hypertension in the Ukrainian population. Ukr. Cardiol. Journal.
Sirenko YuM, Mishchenko LA, Yena LM, Koval SM, Radchenko HD, Rekovets OL. Classification and standards of medical care for patients with hypertension of the Association of Cardiologists of Ukraine. Art. Hypertension.
Ambrosino I, Gallone MS, Patano F, Giannico OV, Barbagelata E, Gnerre P, et al. Gender differences in chronic obstructive pulmonary disease: an analysis of hospitalization indicators. ITJM. 2019.13(1):38–44. DOI: https://doi.org/10.4081/itjm.2019.1099.
Ambrosino P, Lupoli R, Cafaro G, Iervolino S, Carone M, Pappone N, et al. Subclinical carotid atherosclerosis in patients with chronic obstructive pulmonary disease: a meta-analysis of literature studies. Annals of Medicine. 2017;49(6):513–24. DOI: https://doi.org/10.1080/07853890.2017.1311022.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Medical Communications Resources; 2017.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Medical Communications Resources; 2018.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Medical Communications Resources; 2019.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Report 2020). Medical Communications Resources; 2020. Available from: https://goldcopd.org/gold-reports/
Guidelines for the management of arterial hypertension ESC/ESH. Eur Heart J. 2018;39(33):3021-104.
Spyratos D, Sichletidis L. Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review. Therapeut Clin Risk Manag. 2015;11:481-7.
Sun Z. Aging, arterial stiffness and hypertension. Hypertension. 2015;65(2):252–6.
Zhang Y, Ly C, Yannoutsos A, Agnoletti D, Mourad J, Safar ME, et al. Effect of a fixed combination of Perindopril and Amlodipine on blood pressure control in 6256 patients with not-at-goal hypertension: The AVANT’AGE Study. J Am Soc Hypertens. 2013;7(2):163–9.
Zheng X, Jin C, Liu Y, Zhang J, Zhu Y, Kan S, et al. Arterial Stiffness as a Predictor of Clinical Hypertension. J Clin Hypertens. 2015;17:582–91.
